News Releases Year None201920182017 Apr 02, 2019 Axonics® to Present at the Needham Healthcare Conference Additional Formats PDF Version Mar 07, 2019 Axonics® to Participate in Upcoming Investor Events Additional Formats PDF Version Mar 05, 2019 Axonics® Announces Fourth Quarter and Full Year 2018 Financial Results and Operational Update Additional Formats PDF Version Mar 04, 2019 Axonics® Appoints Michael H. Carrel to its Board of Directors Additional Formats PDF Version Feb 26, 2019 Axonics® Submits Pivotal Clinical Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version Feb 22, 2019 Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans Additional Formats PDF Version Feb 19, 2019 Axonics® Announces Positive Top-Line Clinical Data from its ARTISAN-SNM Pivotal Study Additional Formats PDF Version Feb 14, 2019 Axonics® to Report 2018 Fourth Quarter and Full-Year Financial Results and Host a Conference Call on March 5 Additional Formats PDF Version Feb 12, 2019 Axonics® Submits Full Body MRI Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version Jan 02, 2019 Axonics® Submits Interim Clinical Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Print Page Email Page Email Alerts RSS Feeds
News Releases Year None201920182017 Apr 02, 2019 Axonics® to Present at the Needham Healthcare Conference Additional Formats PDF Version Mar 07, 2019 Axonics® to Participate in Upcoming Investor Events Additional Formats PDF Version Mar 05, 2019 Axonics® Announces Fourth Quarter and Full Year 2018 Financial Results and Operational Update Additional Formats PDF Version Mar 04, 2019 Axonics® Appoints Michael H. Carrel to its Board of Directors Additional Formats PDF Version Feb 26, 2019 Axonics® Submits Pivotal Clinical Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version Feb 22, 2019 Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans Additional Formats PDF Version Feb 19, 2019 Axonics® Announces Positive Top-Line Clinical Data from its ARTISAN-SNM Pivotal Study Additional Formats PDF Version Feb 14, 2019 Axonics® to Report 2018 Fourth Quarter and Full-Year Financial Results and Host a Conference Call on March 5 Additional Formats PDF Version Feb 12, 2019 Axonics® Submits Full Body MRI Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version Jan 02, 2019 Axonics® Submits Interim Clinical Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version Pagination First page « first Previous page ‹ previous Page 1 Current page 2
Mar 05, 2019 Axonics® Announces Fourth Quarter and Full Year 2018 Financial Results and Operational Update Additional Formats PDF Version
Mar 04, 2019 Axonics® Appoints Michael H. Carrel to its Board of Directors Additional Formats PDF Version
Feb 26, 2019 Axonics® Submits Pivotal Clinical Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version
Feb 22, 2019 Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans Additional Formats PDF Version
Feb 19, 2019 Axonics® Announces Positive Top-Line Clinical Data from its ARTISAN-SNM Pivotal Study Additional Formats PDF Version
Feb 14, 2019 Axonics® to Report 2018 Fourth Quarter and Full-Year Financial Results and Host a Conference Call on March 5 Additional Formats PDF Version
Feb 12, 2019 Axonics® Submits Full Body MRI Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version
Jan 02, 2019 Axonics® Submits Interim Clinical Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System Additional Formats PDF Version
